| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Interest income | -644,166 | NaN | 955,189 | NaN |
| Other revenues | -105,207 | NaN | 148,010 | NaN |
| Total consolidated revenues | -749,373 | NaN | 1,103,199 | NaN |
| Interest expense | -207,296 | NaN | 294,415 | NaN |
| Segment net interest income and noninterest income | -542,077 | NaN | 808,784 | NaN |
| Credit loss expense | -6,006 | NaN | 6,506 | NaN |
| Salaries and employee benefits | -126,741 | NaN | 189,977 | NaN |
| Occupancy and equipment | -28,409 | NaN | 43,276 | NaN |
| Data processing expense | -16,909 | NaN | 25,793 | NaN |
| Merger and acquisition expenses | 394 | NaN | NaN | NaN |
| Other expense | -19,953 | NaN | 31,018 | NaN |
| Fdic and state assessment | -6,669 | NaN | 8,268 | NaN |
| Electronic banking expense | -6,258 | NaN | 9,584 | NaN |
| Other segment items | -25,286 | NaN | 35,890 | NaN |
| Income tax expense | -67,233 | NaN | 101,256 | NaN |
| Net income | 118,209 | 118,225 | 123,604 | 233,612 |
| Recovery of credit losses - unfunded commitments | NaN | NaN | -1,000 | 0 |
| Depreciation & amortization | 7,456 | 7,446 | 7,428 | 14,318 |
| Decrease (increase) in value of equity securities | 1,248 | -1,173 | -1,020 | -204 |
| Increase in value of equity method investments | 1,321 | 891 | 1,750 | 8,958 |
| Increase in value of foreclosed assets | 0 | NaN | NaN | NaN |
| Amortization of securities, net | 2,985 | 2,959 | 3,323 | 6,545 |
| Accretion of purchased loans | 1,061 | 1,265 | 1,272 | 2,611 |
| Share-based compensation | 3,213 | 2,613 | 2,653 | 5,456 |
| Gain (loss) on assets | 712 | 522 | 166 | 1,977 |
| Gain on repurchase of subordinated debentures | NaN | 0 | 1,882 | NaN |
| Provision for credit losses - loans | 1,500 | 14,400 | 6,700 | 3,000 |
| Recovery of credit losses - unfunded commitments | NaN | -1,000 | NaN | NaN |
| Recovery of credit losses - investment securities | NaN | -1 | -2,194 | NaN |
| Recovery of credit losses - unfunded commitments | -1,000 | NaN | NaN | NaN |
| Deferred income tax effect | 8,166 | 2,689 | 2,229 | 5,430 |
| Increase in cash value of life insurance | 1,368 | 1,400 | 1,404 | 3,257 |
| Originations of mortgage loans held for sale | 156,716 | 196,536 | 191,384 | 349,313 |
| Proceeds from sales of mortgage loans held for sale | 158,832 | 156,492 | 182,290 | 293,136 |
| Accrued interest receivable | -2,311 | -1,763 | 2,970 | -12,397 |
| Other assets | -1,099 | -3,724 | -4,432 | 34,086 |
| Accrued interest payable and other liabilities | 7,994 | -19,818 | -12,453 | 21,924 |
| Return of (purchase of) investment on cash value of life insurance | NaN | 0 | -623 | -6,161 |
| Net cash provided by operating activities | 150,835 | 88,705 | 115,164 | 195,412 |
| Net increase in federal funds sold | -3,025 | 625 | -1,025 | 1,125 |
| Net decrease (increase) in loans | -47,238 | 367,779 | 99,463 | 361,119 |
| Purchases of investment securities available-for-sale | 25,802 | 33,724 | 60,595 | 19,521 |
| Proceeds from maturities of investment securities available-for-sale | 73,110 | 106,690 | 102,789 | 212,672 |
| Proceeds from maturities of investment securities held-to-maturity | 2,765 | 4,071 | 2,189 | 9,995 |
| Purchases of equity securities | NaN | 0 | 0 | 5,000 |
| Proceeds from sales of equity securities | NaN | 2,429 | NaN | NaN |
| Redemption of other investments | -2,255 | 11,660 | -1,508 | -10,152 |
| Proceeds from redemption of other investments | NaN | 13,221 | NaN | NaN |
| Oreo improvements | NaN | 3,493 | NaN | NaN |
| Purchases for improvements to foreclosed assets | -2,764 | NaN | 178 | 2,747 |
| Proceeds from sale of foreclosed assets | 1,459 | 3,255 | 1,360 | 7,014 |
| Proceeds from sale of sba loans | 1,285 | 5,641 | 690 | 4,308 |
| Purchases of premises and equipment | 11,579 | 4,468 | 2,915 | 14,882 |
| Proceeds from sale of premises and equipment | 1,468 | 4,334 | 2,726 | 11,749 |
| Net cash provided by (used in) investing activities | 89,013 | -277,933 | -52,291 | -140,093 |
| Net increase in deposits | 258,318 | 152,261 | -160,736 | 342,135 |
| Net increase (decrease) in securities sold under agreements to repurchase | 1,606 | 9,805 | 5,185 | -21,537 |
| Increase in fhlb and other borrowed funds | NaN | 0 | 0 | 0 |
| Decrease in fhlb and other borrowed funds | 0 | 50,250 | 0 | 50,250 |
| Retirement of subordinated debentures | NaN | 0 | 158,049 | NaN |
| Proceeds from exercise of stock options, net | 0 | 0 | 0 | 602 |
| Repurchase of common stock | 13,893 | 14,906 | 10,021 | 57,293 |
| Dividends paid on common stock | 41,293 | 41,265 | 39,405 | 78,250 |
| Net cash provided by financing activities | 204,738 | 55,645 | -363,026 | 135,407 |
| Net change in cash and cash equivalents | 444,586 | -133,583 | -300,153 | 190,726 |
| Cash and cash equivalents beginning of year | 667,337 | 800,920 | 910,347 | NaN |
| Cash and cash equivalents end of period | 1,111,923 | 667,337 | 800,920 | NaN |
HOME BANCSHARES INC (HOMB)
HOME BANCSHARES INC (HOMB)